Comparison of the cellular and biochemical properties of Plasmodium falciparum choline and ethanolamine kinases

Biochemical Journal

Volumn 425, Issue 1, 2010, Pages 149-158

  Alberge, Blandine ^a   Gannoun Zaki, Leila ^a   Bascunana, Céline ^a,b   Tran Van Ba, Christophe ^a   Vial, Henri ^a   Cerdan, Rachel ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b CEA Marcoule   (France)

Author keywords

Choline kinase (Cho kinase; CK); Ethanolamine kinase (Etn kinase; EK); Inhibition; Kinetic parameter; Phospholipid metabolism (PL metabolism); Plasmodium falciparum

Indexed keywords

CHOLINE KINASE; CHOLINE KINASE (CHO KINASE CK); ETHANOLAMINE KINASE (ETN KINASE EK); ETHANOLAMINES; INHIBITION KINETICS; PLASMODIUM FALCIPARUM;

AMINES; AMMONIUM COMPOUNDS; ANTIBODIES; BIOSYNTHESIS; CYTOLOGY; ESCHERICHIA COLI; KINETIC PARAMETERS; METABOLISM; PHOSPHOLIPIDS;

BIOCHEMISTRY;

2 AMINOBUTANOL; ANTIMALARIAL AGENT; CHOLINE KINASE; ETHANOLAMINE KINASE; HEMICHOLINIUM 3; PHOSPHATIDYLCHOLINE; POLYCLONAL ANTIBODY; RECOMBINANT CHOLINE KINASE; RECOMBINANT ENZYME; RECOMBINANT ETHANOLAMINE KINASE; SAR 97276; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; ERYTHROPOIESIS; ESCHERICHIA COLI; GENE OVEREXPRESSION; MICHAELIS MENTEN KINETICS; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS;

AMINO ALCOHOLS; ANTIMALARIALS; BINDING SITES; BLOTTING, WESTERN; CATALYSIS; CHOLINE; CHOLINE KINASE; CIRCULAR DICHROISM; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; ETHANOLAMINES; HEMICHOLINIUM 3; KINETICS; MICROSCOPY, FLUORESCENCE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PLASMODIUM FALCIPARUM; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; THIAZOLES;

ESCHERICHIA COLI; MURINAE; PLASMODIUM FALCIPARUM;

EID: 72449122478     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20091119     Document Type: Article

References (48)

1. Vial, H. and Ancelin, M.-L. (1992) Malarial lipids: an overview. In Subcellular Biochemistry, Volume 18: Intracellular Parasites (Avila, J. L. and Harris, J. R., eds), pp. 259-306, Plenum Press, New York
2. Vial, H. J., Eldin, P., Tielens, A. G. M. and van Hellemond, J. J. (2003) Phospholipids in parasitic protozoa. Mol. Biochem. Parasitol. 126, 143-154
3. Holz, G. G. (1977) Lipids and the malaria parasite. Bull. World Health Organ. 55, 237-248
4. Vial, H. and Ben Mamoun, C. (2005) Plasmodium lipids: metabolism and function. In Molecular Approaches to Malaria (Sherman, I. W., ed.), pp. 327-352, ASM Press, Washington, DC
5. Elabbadi, N., Ancelin, M. L. and Vial, H. J. (1997) Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation. Biochem. J. 324, 435-445
6. Pessi, G., Choi, J. Y., Reynolds, J. M., Voelker, D. R. and Mamoun, C. B. (2005) In vivo evidence for the specificity of Plasmodium falciparum phosphoethanolamine methyltransferase and its coupling to the Kennedy pathway. J. Biol. Chem. 280, 12461-12466
7. Pessi, G., Kociubinski, G. and Ben Mamoun, C. (2004) A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation. Proc. Natl. Acad. Sci. U.S.A. 101, 6206-6211
8. Salom-Roig, X. J., Hamzé, A., Calas, M. and Vial, H. J. (2005) Dual molecules as new antimalarials. Comb. Chem. High Throughput Screen. 8, 47-60
9. Vial, H. and Calas, M. (2000) Inhibitors of phospholipid metabolism. In Antimalarial Chemotherapy, Mechanisms of Action, Modes of Resistance, and New Directions in Drug Development (Rosenthal, P., ed.), pp. 347-365, Humana Press, Totowa, NJ, U.S.A.
10. Vial, H. J., Thuet, M. J., Ancelin, M. L., Philippot, J. R. and Chavis, C. (1984) Phospholipid metabolism as a new target for malaria chemotherapy. Mechanism of action of D-2-amino-1-butanol. Biochem. Pharmacol. 33, 2761-2770
11. Calas, M., Ancelin, M. L., Cordina, G., Portefaix, P., Piquet, G., Vidal-Sailhan, V. and Vial, H. (2000) Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts. J. Med. Chem. 43, 505-516
12. Ancelin, M. L., Calas, M., Bonhoure, A., Herbute, S. and Vial, H. J. (2003) In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism. Antimicrob. Agents Chemother. 47, 2598-2605
13. Vial, H. J., Wein, S., Farenc, C., Kocken, C., Nicolas, O., Ancelin, M. L., Bressolle, F., Thomas, A. and Calas, M. (2004) Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc. Natl. Acad. Sci. U.S.A. 101, 15458-15463
14. Biagini, G. A., Pasini, E., Hughes, R., De Koning, H. P., Vial, H., O'Neill, P., Ward, S. and Bray, P. (2004) Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood 104, 3372-3377
15. Vial, H. J., Thuet, M. J. and Philippot, J. R. (1984) Cholinephosphotransferase and ethanolaminephosphotransferase activities in Plasmodium knowlesi-infected erythrocytes. Their use as parasite-specific markers. Biochim. Biophys. Acta 795, 372-383
16. Ramirez de Molina, A., Gallego-Ortega, D., Sarmentero-Estrada, J., Lagares, D., Gomez del Pulgar, T., Bandres, E., Garcia-Fontillas, J. and Lacal, J. C. (2008) Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: implications in cancer therapy. Int. J. Biochem. Cell Biol. 40, 1753-1763
17. Glunde, K., Jie, C. and Bhujwalla, Z. M. (2004) Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res. 64, 4270-4276
18. Cui, Z. and Houweling, M. (2002) Phosphatidylcholine and cell death. Biochim. Biophys. Acta 1585, 87-96
19. Eliyahu, G., Kreizman, T. and Degani, H. (2007) Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int. J. Cancer 120, 1721-1730
20. Rodriguez-Gonzalez, A., de Molina, A. R., Fernandez, F., Ramos, M. A., Nunez, M. D., Campos, J. and Lacal, J. C. (2003) Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells. Oncogene 22, 8803-8812
21. Rodriguez-Gonzales, A., de Molina, A. R., Fernandez, F. and Lacal, J. C. (2004) Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action. Oncogene 23, 8247-8259
22. Banez-Coronel, M., de Molina, A. R., Rodriguez-Gonzalez, A., Sarmentero, J., Ramos, M. A., Garcia-Cabezas, M. A., Garcia-Oroz, L. and Lacal, J. C. (2008) Choline kinase alpha depletion selectively kills tumoral cells. Curr. Cancer Drug Targets 8, 709-719
23. Milanese, L., Espinosa, A., Campos, J. M., Gallo, M. A. and Entrena, A. (2006) Insight into the inhibition of human choline kinase: homology modeling and molecular dynamics simulations. ChemMedChem 1, 1216-1228
24. Campos, J., Nunez, M. D., Rodriguez, V., Gallo, M. A. and Espinosa, A. (2000) QSAR of 1,1′-(1,2-ethylenebisbenzyl)bis(4-substitutedpyridinium) dibromides as choline kinase inhibitors: a different approach for antiproliferative drug design. Bioorg. Med. Chem. Lett. 10, 767-770
25. Campos, J., Nunez, M. C., Conejo-Garcia, A., Sanchez-Martin, R. M., Hernandez-Alcoceba, R., Rodriguez-Gonzalez, A., Lacal, J. C., Gallo, M. A. and Espinosa, A. (2003) QSAR-derived choline kinase inhibitors: how rational can antiproliferative drug design be? Curr. Med. Chem. 10, 1095-1112
26. Janardhan, S., Srivani, P. and Sastry, G. N. (2006) 2D and 3D quantitative structure-activity relationship studies on a series of bis-pyridinium compounds as choline kinase inhibitors. Qsar Comb. Sci. 25, 860-872
27. Nunez, M. C., Conejo-Garcia, A., Sanchez-Martin, R. M., Gallo, M. A., Espinosa, A. and Campos, J. M. (2007) QSAR as a tool for the development of potent antiproliferative agents by inhibition of choline kinase. Curr. Comput. Aided Drug Des. 3, 297-312
28. Ancelin, M. L. and Vial, H. J. (1986) Several lines of evidence demonstrating that Plasmodium falciparum, a parasitic organism, has distinct enzymes for the phosphorylation of choline and ethanolamine. FEBS Lett. 202, 217-223
29. Choubey, V., Guha, M., Maity, P., Kumar, S., Raghunandan, R., Maulik, P. R., Mitra, K., Halder, U. C. and Bandyopadhyay, U. (2006) Molecular characterization and localization of Plasmodium falciparum choline kinase. Biochim. Biophys. Acta 1760, 1027-1038
30. Choubey, V., Maity, P., Guha, M., Kumar, S., Srivastava, K., Kumar Puri, S. and Bandyopadhyay, U. (2007) Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism. Antimicrob. Agents Chemother. 51, 696-706
31. Aurrecoechea, C., Brestelli, J., Brunk, B. P., Dommer, J., Fischer, S., Gajria, B., Gao, X., Gingle, A., Grant, G., Harb, O. S. et al. (2009) PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 37, D539-D543
32. Lambros, C. and Vanderberg, J. P. (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65, 418-420
33. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
34. Ancelin, M. L. and Vial, H. J. (1986) Choline kinase activity in Plasmodium-infected erythrocytes: characterization and utilization as a parasite-specific marker in malarial fractionation studies. Biochim. Biophys. Acta 875, 52-58
35. Aoyama, C., Liao, H. and Ishidate, K. (2004) Structure and function of choline kinase isoforms in mammalian cells. Prog. Lipid Res. 43, 266-281
36. Malito, E., Sekulic, N., Cun See Too, W., Konrad, M. and Lavie, A. (2006) Elucidation of human choline kinase crystal structures in complex with the products ADP or phosphocholine. J. Mol. Biol. 364, 136-151
37. Yuan, C. and Kent, C. (2004) Identification of critical residues of choline kinase A2 from Caenorhabditis elegans. J. Biol. Chem. 279, 17801-17809
38. Gee, P. and Kent, C. (2003) Multiple isoforms of choline kinase from Caenorhabditis elegans: cloning, expression, purification, and characterization. Biochim. Biophys. Acta 1648, 33-42
39. Gibellini, F., Hunter, W. N. and Smith, T. K. (2008) Biochemical characterization of the initial steps of the Kennedy pathway in Trypanosoma brucei: the ethanolamine and choline kinases. Biochem. J. 415, 135-144
40. Kim, K. H., Voelker, D. R., Flocco, M. T. and Carman, G. M. (1998) Expression, purification, and characterization of choline kinase, product of the CKI gene from Saccharomyces cerevisiae. J. Biol. Chem. 273, 6844-6852
41. Peisach, D., Gee, P., Kent, C. and Xu, Z. (2003) The crystal structure of choline kinase reveals a eukaryotic protein kinase fold. Structure 11, 703-713
42. Zlatkine, P., Moll, G., Blais, A., Loiseau, A. and Legrimellec, C. (1993) Transport of choline by Madin-Darby canine kidney-cells. Biochim. Biophys. Acta 1153, 237-242
43. Hamza, M., Lloveras, J., Ribbes, G., Soula, G. and Dousteblazy, L. (1983) An in vitro study of hemicholinium-3 on phospholipid-metabolism of Krebs II ascites cells. Biochem. Pharmacol. 32, 1893-1897
44. Cuadrado, A., Carnero, A., Dolfi, F., Jimenez, B. and Lacal, J. C. (1993) Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene 8, 2959-2968
45. Lacal, J. C. (2001) Choline kinase: a novel target for antitumor drugs. IDrugs 4, 419-426
46. Hamze, A., Rubi, E., Arnal, P., Boisbrun, M., Carcel, C., Salom-Roig, X., Maynadier, M., Wein, S., Vial, H. and Calas, M. (2005) Mono- and bis-thiazolium salts have potent antimalarial activity. J. Med. Chem. 48, 3639-3643
47. Kim, K. S., Kim, K. H., Storey, M. K., Voelker, D. R. and Carman, G. M. (1999) Isolation and characterization of the Saccharomyces cerevisiae EKI1 gene encoding ethanolamine kinase. J. Biol. Chem. 274, 14857-14866
48. Lykidis, A., Wang, J., Karim, M. A. and Jackowski, S. (2001) Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway. J. Biol. Chem. 276, 2174-2179